Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men
Open accessThe DOI matches its Crossref record; 56 of the 62 references it cites were found in a registry or an index; 13 of the 57 sources its claims cite were checked for support.
Abstract
OBJECTIVE: Short sleep duration is associated with impaired glucose tolerance and an increased risk of diabetes. The effects of sleep restriction on insulin sensitivity have not been established. This study tests the hypothesis that decreasing nighttime sleep duration reduces insulin sensitivity and assesses the effects of a drug, modafinil, that increases alertness during wakefulness. RESEARCH DESIGN AND METHODS: This 12-day inpatient General Clinical Research Center study included 20 healthy men (age 20–35 years and BMI 20–30 kg/m2). Subjects spent 10 h/night in bed for ≥8 nights including three inpatient nights (sleep-replete condition), followed by 5 h/night in bed for 7 nights (sleep-restricted condition). Subjects received 300 mg/day modafinil or placebo during sleep restriction. Diet and activity were controlled. On the last 2 days of each condition, we assessed glucose metabolism by intravenous glucose tolerance test (IVGTT) and euglycemic-hyperinsulinemic clamp. Salivary cortisol, 24-h urinary catecholamines, and neurobehavioral performance were measured. RESULTS: IVGTT-derived insulin sensitivity was reduced by (means ± SD) 20 ± 24% after sleep restriction (P = 0.001), without significant alterations in the insulin secretory response. Similarly, insulin sensitivity assessed by clamp was reduced by 11 ± 5.5% (P < 0.04) after sleep restriction. Glucose tolerance and the disposition index were reduced by sleep restriction. These outcomes were not affected by modafinil treatment. Changes in insulin sensitivity did not correlate with changes in salivary cortisol (increase of 51 ± 8% with sleep restriction, P < 0.02), urinary catecholamines, or slow wave sleep. CONCLUSIONS: Sleep restriction (5 h/night) for 1 week significantly reduces insulin sensitivity, raising concerns about effects of chronic insufficient sleep on disease processes associated with insulin resistance.
Overview
CoChat Summary
TL;DR
In healthy men, restricting sleep to 5 h/night for 1 week reduced insulin sensitivity by both IVGTT and euglycemic-hyperinsulinemic clamp, without altering insulin secretion. Modafinil improved sleepiness but did not affect glucose metabolism.
Key findings
- IVGTT-derived insulin sensitivity (SI) fell by 20 ± 24% after sleep restriction (P = 0.001), with 15 of 19 subjects showing a decrease.
- Clamp-derived insulin sensitivity (M) fell by 11 ± 5.5% after sleep restriction (P < 0.04; results report P = 0.045), and 90% of subjects had a decrease.
- Glucose tolerance and the disposition index were also reduced by sleep restriction, while the acute insulin response was not significantly affected.
- Modafinil did not affect any metabolic outcomes, although it reduced subjective and objective sleepiness; cortisol increased with sleep restriction but changes in insulin sensitivity did not correlate with cortisol, urinary catecholamines, or slow-wave sleep.
Methods
- Double-blind, placebo-controlled, randomized 12-day inpatient General Clinical Research Center study in 20 healthy men (mean ± SD age 26.8 ± 5.2 years; BMI 23.3 ± 3.1 kg/m²; 11 placebo, 9 modafinil).
- Subjects spent 10 h/night in bed for ≥8 nights including three inpatient baseline nights, then 5 h/night in bed for 7 nights; diet and activity were controlled, and modafinil (300 mg/day) or placebo was given during sleep restriction.
- Glucose metabolism was assessed on the last 2 days of each condition by insulin-modified frequently sampled IVGTT and euglycemic-hyperinsulinemic clamp; mixed-effects models tested sleep restriction, drug, and interaction effects.
Limitations
- The paper states a small sample limited to healthy nonobese men and no control group that continued the 10 h/night sleep-replete condition through to study end.
- The paper notes that controlled food intake may have dampened the full effects of sleep restriction, and circadian phase was not measured directly, though modeling estimated <9 min variation.
- Evident from the text: three additional subjects withdrew after starting modafinil because of transient EKG changes, tachycardia, and elevated blood pressure, so tolerability and generalizability are further constrained.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![FIG. 3. Salivary (free) cortisol levels with sleep restriction. Salivary cortisol levels were assessed hourly from 1500 to 2100 h under sleep-replete conditions (10 h/night TIB [black circles]) and under sleep-restricted conditions (5 h/night TIB for 1 week) in subjects receiving placebo (red circles) or modafinil (green triangles). Salivary cortisol levels (means ± SD) from 1500 to 2100 h were significantly affected by sleep duration only: 0.13 ± 0.03 ng/ml for the sleep-replete condition and 0.17 ± 0.04 ng/ml for the sleep-restricted condition (P < 0.0001 and Table 1). Identical (mixed composition) dinners were served just after the 1800-h saliva sample and finished before 1840 h.](https://figures.cochat.ai/paper-figures/f8945d03b73041b7a33593b8310e4124/sleep-restriction-for-1-week-reduces-insulin-sensitivity-in-healthy-men-figure-3.jpg)
![FIG. 4. Effects of sleep restriction on glucose metabolism. A and B: Mean glucose levels (± SE) from IVGTT during the baseline sleep-replete condition (10 h/night TIB [black line]) and following sleep restriction for 1 week (5 h/night TIB) in subjects receiving placebo (A) (red line) modafinil (B) (green line). Left arrow, glucose infusion at time = 0 min; right arrow, insulin infusion at time = 20 min. C and D: Mean insulin levels (± SE) from IVGTT. E–H: IVGTT parameters were calculated using Minmod Millennium software. Glucose and insulin data from insulin-modified IVGTT procedures under sleep-replete (filled symbols) and sleep-restricted conditions (open symbols) are shown. E: Acute insulin response (AIRg) (first phase). F: Disposition index. G: SI from IVGTT. H: relative changes in SI from IVGTT expressed as percent change from baseline sleep-replete condition in subjects randomized to placebo (red circles) or modafinil administration (green triangles). I: Insulin sensitivity (M) from euglycemic-hyperinsulinemic clamp procedure. J: Relative changes in insulin sensitivity (M) depicted as in F. There were no significant effects of drug administration on any metabolic parameters (Table 1).](https://figures.cochat.ai/paper-figures/97db451da74e49b7bc35ed683d01f565/sleep-restriction-for-1-week-reduces-insulin-sensitivity-in-healthy-men-figure-4.jpg)
Verification
Claims the paper makes
9 Valid · 0 Not valid · 22 Not checked · 71 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In prospective studies, decreases in the disposition index, the product of insulin secretion and SI, are a strong predictor of diabetes onset and worsening of metabolic function pre- and postdiagnosis (53).”
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > DISCUSSION
What the sources say
- Partly supportedcites [53] Lyssenko, 2008, Clinical risk factors, DNA variants, and the development of type 2 diabetes, N Engl J Med sourceExperimental — accuracy not yet measured
The Measurements section defines the disposition index as insulin secretion adjusted for insulin sensitivity (CIR × ISI), and Clinical Factors Predicting Incidence of Diabetes calls it a strong predictor of future diabetes. The cited passages do not establish that decreases in the index predict worsening metabolic function both before and after diagnosis; the reported longitudinal analysis concerns subjects who did not have diabetes. (LLM, conf=0.88)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“changes in insulin sensitivity (M) assessed by the clamp procedure correlated with the change in insulin sensitivity (SI) assessed by the IVGTT procedure (r = 0.53; P = 0.02).”
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > RESULTS > Insulin sensitivity (euglycemic-hyperinsulinemic clamp).
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were no significant effects of sleep restriction or drug treatment on other minimal model parameters (Table 1).”
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > RESULTS > Insulin sensitivity and acute insulin response (IVGTT).
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ninety percent of subjects had a decrease in M with sleep restriction.”
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > RESULTS > Insulin sensitivity (euglycemic-hyperinsulinemic clamp).
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“there was a strong correlation of the absolute level of M with SI (r = 0.85; P < 0.0001).”
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > RESULTS > Insulin sensitivity (euglycemic-hyperinsulinemic clamp).
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
48 more claims
Create a free account to see all 102 claims and to verify the 2 references still open.
- It may state two separate claims as one. 22
- Probably not a substantial claim. 33
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Experimental sleep restriction in healthy adults results in increases in insulin resistance99 and decreases in insulin sensitivity.81”
From Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association (2016) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“increased predisposition to obesity (3) and insulin resistance (IR) (4) in both adults and children”
From Sleep architecture and glucose and insulin homeostasis in obese adolescents (2011) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In humans, transient misalignment of behaviors and the circadian clock increases inflammation and impairs glucose regulation (137-140), with potential relevance to CV disease (141).”
From Role of the circadian system in cardiovascular disease (2018) · cites this paper as [138]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“several others have found elevated cortisol in the latter part of the day instead of the usual diurnal decline [17], [18], [54].”
From Impact of Five Nights of Sleep Restriction on Glucose Metabolism, Leptin and Testosterone in Young Adult Men (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This test has been used to show an adverse effect of sleep disturbances on human glucose metabolism and insulin sensitivity in multiple previous reports (12, 15,17, 23, 24). In 1 study that used both the FSIVGTT and the euglycemic hyperinsulinemic clamp to assess changes in insulin sensitivity after experimental sleep restriction in healthy participants, both methods provided similar results (12).”
From Impaired Insulin Signaling in Human Adipocytes After Experimental Sleep Restriction: A Randomized, Crossover Study (2012) · cites this paper as [12]
17 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > RESULTS > Insulin sensitivity (euglycemic-hyperinsulinemic clamp).
“The dextrose infusion rate (M) needed to maintain euglycemia during the final hour of the clamp procedure was significantly reduced with sleep restriction compared with the baseline sleep-replete condition (Fig. 4G and H)”
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > RESULTS > Insulin sensitivity and acute insulin response (IVGTT).
“G: SI from IVGTT. H: relative changes in SI from IVGTT expressed as percent change from baseline sleep-replete condition in subjects randomized to placebo (red circles) or modafinil administration (green triangles). I: Insulin sensitivity (M) from euglycemic-hyperinsulinemic clamp procedure. J: Relative changes in insulin sensitivity (M) depicted as in F.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > RESULTS > Insulin sensitivity and acute insulin response (IVGTT).
“with a mean decrease of 20 ± 24% (F1,18 = 15.18; P = 0.001) (Table 1 and Fig. 4E and F)”
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > RESULTS > Insulin sensitivity and acute insulin response (IVGTT).
“E: Acute insulin response (AIRg) (first phase). F: Disposition index. G: SI from IVGTT. H: relative changes in SI from IVGTT”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > Abstract > RESULTS
“insulin sensitivity assessed by clamp was reduced by 11 ± 5.5% (P < 0.04) after sleep restriction”
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > RESULTS > Insulin sensitivity (euglycemic-hyperinsulinemic clamp).
“The mean ± SE decrease for all subjects was 11 ± 5.5% (F1.18 = 4.64; P = 0.045)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > RESULTS > Cortisol and norepinephrine.
“0.13 ± 0.03 ng/ml for the sleep-replete condition and 0.17 ± 0.04 ng/ml for the sleep-restricted condition”
§ Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men > RESULTS > Subjective and objective measures of sleepiness.
“| Salivary cortisol (ng/ml) | 0.179 ± 0.017 | 0.112 ± 0.013 | 0.180 ± 0.015 | 0.125 ± 0.010 | <0.0001 | 0.70 | 0.48 |”
Citations
Cites
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,638
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“(36), was determined and used as an indicator of insulin sensitivity.”
MethodAllan Hobson, J. (1969) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(69)90021-2 · Cited by 5,192
Impact of sleep debt on metabolic and endocrine function
Spiegel, K., Leproult, R., & Van Cauter, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01376-8 · Cited by 3,668 · cited 3×
“(22) from the Van Cauter laboratory performed frequently sampled IVGTT (FSIVGTT) in healthy subjects during a sleep debt condition (4 h per night) and the sleep-replete condition (12 h/night).”
BackgroundInfluentialVan Dongen, H. P. A., Maislin, G., Mullington, J. M., & Dinges, D. F. (2003) · Sleep · doi:10.1093/sleep/26.2.117 · Cited by 3,173
Spiegel, K., Tasali, E., Penev, P., & Cauter, E. V. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-11-200412070-00008 · Cited by 2,459 · cited 1×
“Previous studies have shown that sleep restriction increases self-reported hunger and appetite for carbohydrate food (41,42).”
BackgroundMortality Associated With Sleep Duration and Insomnia
Kripke, D. F., Garfinkel, L., Wingard, D. L., Klauber, M. R., & Marler, M. R. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.2.131 · Cited by 1,614 · cited 2×
“hypertension (12), cardiovascular disease (13;14), the metabolic syndrome (15), and early mortality (14;16-21).”
BackgroundBelenky, G., Wesensten, N. J., Thorne, D. R., Thomas, M. L., Sing, H. C., Redmond, D. P., Russo, M. B., & Balkin, T. J. (2003) · Journal of Sleep Research · doi:10.1046/j.1365-2869.2003.00337.x · Cited by 1,436 · cited 1×
“Modafanil activates central, wake-promoting dopaminergic and noradrenergic mechanisms (25;26) and ameliorates the adverse effects of sleep deprivation on alertness and performance (27-29), impairments in which have been attributed to reduced brain glucose utilization (30).”
BackgroundThe metabolic consequences of sleep deprivation
Knutson, K. L., Spiegel, K., Penev, P., & Van Cauter, E. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.01.002 · Cited by 1,365 · cited 1×
“has fallen below 7 h per night, a drop of 2 h per night over the last century and 1 h per night over the last 40 years (1,2).”
BackgroundSleep loss: a novel risk factor for insulin resistance and type 2 diabetes
Spiegel, K., Knutson, K., Leproult, R., Tasali, E., & Cauter, E. V. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00660.2005 · Cited by 1,175
Punjabi, N. M. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh261 · Cited by 1,107
Spiegel, K., Leproult, R., L’Hermite-Balériaux, M., Copinschi, G., Penev, P. D., & Van Cauter, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1003 · Cited by 1,006 · cited 1×
“Both these pathways also have been proposed as possible mediators of the impairments in glucose tolerance associated with sleep restriction (22;44-48).”
BackgroundAssociation of usual sleep duration with hypertension: the Sleep Heart Health Study
Gottlieb, D. J., Redline, S., Nieto, F. J., Baldwin, C. M., Newman, A. B., Resnick, H. E., & Punjabi, N. M. (2006) · Sleep · doi:10.1093/sleep/29.8.1009 · Cited by 947 · cited 2×
“Insufficient sleep duration (quantity) has been associated with an increased risk of obesity (3–6,51), type 2 diabetes (7–11), hypertension (12), cardiovascular disease (13,14), metabolic syndrome (a combination of cardiovascular and metabolic dysfunction) (15), and early mortality (14,16,17,19–21,52).”
BackgroundClinical risk factors, DNA variants, and the development of type 2 diabetes
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., & Groop, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801869 · Cited by 938
Association of sleep time with diabetes mellitus and impaired glucose tolerance
Gottlieb, D. J., Punjabi, N. M., Newman, A. B., Resnick, H. E., Redline, S., Baldwin, C. M., & Nieto, F. J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.8.863 · Cited by 927 · cited 2×
“Insufficient sleep duration (quantity) has been associated with an increased risk of obesity (3-6;51), type 2 diabetes mellitus (7-11), hypertension (12), cardiovascular disease (13;14), metabolic syndrome (a combination of cardiovascular and metabolic dysfunction) (15), and early mortality (14;16;17;19-21;52).”
BackgroundSlow-wave sleep and the risk of type 2 diabetes in humans
Tasali, E., Leproult, R., Ehrmann, D. A., & Van Cauter, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706446105 · Cited by 921
Inadequate Sleep as a Risk Factor for Obesity: Analyses of the NHANES I
Gangwisch, J. E., Malaspina, D., Boden-Albala, B., & Heymsfield, S. B. (2005) · Sleep · doi:10.1093/sleep/28.10.1289 · Cited by 905 · cited 2×
“Insufficient sleep duration (quantity) has been associated with an increased risk of obesity (3-6;51), type 2 diabetes mellitus (7-11), hypertension (12), cardiovascular disease (13;14), metabolic syndrome (a combination of cardiovascular and metabolic dysfunction) (15), and early mortality (14;16;17;19-21;52).”
BackgroundA prospective study of self-reported sleep duration and incident diabetes in women
Ayas, N. T., White, D. P., Al-Delaimy, W. K., Manson, J. E., Stampfer, M. J., Speizer, F. E., Patel, S., & Hu, F. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.380 · Cited by 883 · cited 2×
“Insufficient sleep duration (quantity) has been associated with an increased risk of obesity (3-6;51), type 2 diabetes mellitus (7-11), hypertension (12), cardiovascular disease (13;14), metabolic syndrome (a combination of cardiovascular and metabolic dysfunction) (15), and early mortality (14;16;17;19-21;52).”
BackgroundSleep duration as a risk factor for the development of type 2 diabetes
Yaggi, H. K., Araujo, A. B., & McKinlay, J. B. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-0879 · Cited by 790 · cited 2×
“Insufficient sleep duration (quantity) has been associated with an increased risk of obesity (3-6;51), type 2 diabetes mellitus (7-11), hypertension (12), cardiovascular disease (13;14), metabolic syndrome (a combination of cardiovascular and metabolic dysfunction) (15), and early mortality (14;16;17;19-21;52).”
BackgroundSleep Loss Results in an Elevation of Cortisol Levels the Next Evening
(1997) · Sleep · doi:10.1093/sleep/20.10.865 · Cited by 745 · cited 1×
“Both these pathways also have been proposed as possible mediators of the impairments in glucose tolerance associated with sleep restriction (22;44-48).”
BackgroundSelf-citationSleep curtailment is accompanied by increased intake of calories from snacks
Nedeltcheva, A. V., Kilkus, J. M., Imperial, J., Kasza, K., Schoeller, D. A., & Penev, P. D. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26574 · Cited by 717 · cited 2×
“We did not observe any changes in resting metabolic rate using indirect calorimetry, which is consistent with a prior report of a nonsignificant change in total energy expenditure with sleep restriction (42).”
BackgroundResultHasler, G., Buysse, D. J., Klaghofer, R., Gamma, A., Ajdacic, V., Eich, D., Rössler, W., & Angst, J. (2004) · Sleep · doi:10.1093/sleep/27.4.661 · Cited by 672 · cited 2×
“Insufficient sleep duration (quantity) has been associated with an increased risk of obesity (3-6;51), type 2 diabetes mellitus (7-11), hypertension (12), cardiovascular disease (13;14), metabolic syndrome (a combination of cardiovascular and metabolic dysfunction) (15), and early mortality (14;16;17;19-21;52).”
BackgroundA Prospective Study of Sleep Duration and Mortality Risk in Women
Patel, S. R., Ayas, N. T., Malhotra, M. R., White, D. P., Schernhammer, E. S., Speizer, F. E., Stampfer, M. J., & Hu, F. B. (2004) · Sleep · doi:10.1093/sleep/27.3.440 · Cited by 663 · cited 2×
“hypertension (12), cardiovascular disease (13;14), the metabolic syndrome (15), and early mortality (14;16-21).”
BackgroundA Prospective Study of Endogenous Estrogens and Breast Cancer in Postmenopausal Women
Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., & Pasternack, B. S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.3.190 · Cited by 620
Sleep Duration as a Risk Factor for Diabetes Incidence in a Large US Sample
Gangwisch, J. E., Heymsfield, S. B., Boden-Albala, B., Buijs, R. M., Kreier, F., Pickering, T. G., Rundle, A. G., Zammit, G. K., & Malaspina, D. (2007) · Sleep · doi:10.1093/sleep/30.12.1667 · Cited by 573
Body Fat Distribution and Insulin Resistance in Healthy Asian Indians and Caucasians
Raji, A., Seely, E. W., Arky, R. A., & Simonson, D. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.7992 · Cited by 541 · cited 1×
“Insulin sensitivity was measured using the insulin clamp procedure as previously described (35).”
MethodSelf-citationProspective study of shift work and risk of coronary heart disease in women
Kawachi, I., Colditz, G. A., Stampfer, M. J., Willett, W. C., Manson, J. E., Speizer, F. E., & Hennekens, C. H. (1995) · Circulation · doi:10.1161/01.cir.92.11.3178 · Cited by 524 · cited 2×
“Insufficient sleep duration (quantity) has been associated with an increased risk of obesity (3–6,51), type 2 diabetes (7–11), hypertension (12), cardiovascular disease (13,14), metabolic syndrome (a combination of cardiovascular and metabolic dysfunction) (15), and early mortality (14,16,17,19–21,52).”
BackgroundFerrie, J. E., Shipley, M. J., Cappuccio, F. P., Brunner, E., Miller, M. A., Kumari, M., & Marmot, M. G. (2007) · Sleep · doi:10.1093/sleep/30.12.1659 · Cited by 515 · cited 2×
“hypertension (12), cardiovascular disease (13;14), the metabolic syndrome (15), and early mortality (14;16-21).”
BackgroundMallon, L., Broman, J. ‐., & Hetta, J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00941.x · Cited by 495 · cited 2×
“hypertension (12), cardiovascular disease (13;14), the metabolic syndrome (15), and early mortality (14;16-21).”
BackgroundModulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep
Van Cauter, E., Blackman, J. D., Roland, D., Spire, J. P., Refetoff, S., & Polonsky, K. S. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115396 · Cited by 448
Sleep and Mortality: A Population-Based 22-Year Follow-Up Study
Hublin, C., Partinen, M., Koskenvuo, M., & Kaprio, J. (2007) · Sleep · doi:10.1093/sleep/30.10.1245 · Cited by 439 · cited 1×
“hypertension (12), cardiovascular disease (13;14), the metabolic syndrome (15), and early mortality (14;16-21).”
BackgroundRelations Between Performance and Subjective Ratings of Sleepiness During a Night Awake
Gillberg, M., Kecklund, G., & Åkerstedt, T. (1994) · Sleep · doi:10.1093/sleep/17.3.236 · Cited by 423 · cited 1×
“Every 3 hours during wake periods, subjects completed a short test battery including the Karolinska Sleepiness Scale (34) and the Psychomotor Vigilance Task (PVT) (3,24).”
MethodModafinil for excessive sleepiness associated with shift work sleep disorder
Czeisler, C. A., Walsh, J. K., Roth, T., Hughes, R. J., Wright, K. P., Kingsbury, L., Arora, S., Schwartz, J. R. L., Niebler, G. E., & Dinges, D. F. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041292 · Cited by 413 · cited 1×
“Modafanil activates central, wake-promoting dopaminergic and noradrenergic mechanisms (25;26) and ameliorates the adverse effects of sleep deprivation on alertness and performance (27-29), impairments in which have been attributed to reduced brain glucose utilization (30).”
BackgroundVorona, R. D., Winn, M. P., Babineau, T. W., Eng, B. P., Feldman, H. R., & Ware, J. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.1.25 · Cited by 405 · cited 2×
“Insufficient sleep duration (quantity) has been associated with an increased risk of obesity (3-6;51), type 2 diabetes mellitus (7-11), hypertension (12), cardiovascular disease (13;14), metabolic syndrome (a combination of cardiovascular and metabolic dysfunction) (15), and early mortality (14;16;17;19-21;52).”
BackgroundSome preliminary findings on physical complaints from a prospective study of 1,064,004 men and women
Hammond, E. C. (1964) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.54.1.11 · Cited by 401
Redwine, L., Hauger, R. L., Gillin, J. C., & Irwin, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6871 · Cited by 372 · cited 1×
“Both these pathways also have been proposed as possible mediators of the impairments in glucose tolerance associated with sleep restriction (22;44-48).”
BackgroundSelf-reported sleep quality is associated with the metabolic syndrome
Jennings, J. R., Muldoon, M. F., Hall, M., Buysse, D. J., & Manuck, S. B. (2007) · Sleep · doi:10.1093/sleep/30.2.219 · Cited by 344 · cited 2×
“Insufficient sleep duration (quantity) has been associated with an increased risk of obesity (3–6,51), type 2 diabetes (7–11), hypertension (12), cardiovascular disease (13,14), metabolic syndrome (a combination of cardiovascular and metabolic dysfunction) (15), and early mortality (14,16,17,19–21,52).”
BackgroundConservation of photoperiod-responsive mechanisms in humans
Wehr, T. A., Moul, D. E., Barbato, G., Giesen, H. A., Seidel, J. A., Barker, C., & Bender, C. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.265.4.r846 · Cited by 334 · cited 1×
“, with similar and presumably minimal amounts of sleep debt (31).”
BackgroundNedeltcheva, A. V., Kessler, L., Imperial, J., & Penev, P. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0483 · Cited by 323 · cited 1×
“5 h/night with an ad libitum diet reduces insulin sensitivity but does not change insulin secretion on an IVGTT (40).”
BackgroundMeisinger, C., Heier, M., Löwel, H., Schneider, A., & Döring, A. (2007) · Sleep · doi:10.1093/sleep/30.9.1121 · Cited by 305
Sleep deprivation-induced reduction in cortical functional response to serial subtraction
Drummond, S. P. A., Brown, G. G., Stricker, J. L., Buxton, R. B., Wong, E. C., & Gillin, J. C. (1999) · NeuroReport · doi:10.1097/00001756-199912160-00004 · Cited by 285 · cited 1×
“Modafanil activates central, wake-promoting dopaminergic and noradrenergic mechanisms (25,26) and ameliorates the adverse effects of sleep deprivation on alertness and performance (27–29)— impairments that have been attributed to reduced brain glucose utilization (30).”
BackgroundRedwine, L. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3597 · Cited by 282
Study, T. M. A. C., Meisinger, C., Heier, M., & Loewel, H. (2005) · Diabetologia · doi:10.1007/s00125-004-1634-x · Cited by 234 · cited 2×
“Insufficient sleep duration (quantity) has been associated with an increased risk of obesity (3-6;51), type 2 diabetes mellitus (7-11), hypertension (12), cardiovascular disease (13;14), metabolic syndrome (a combination of cardiovascular and metabolic dysfunction) (15), and early mortality (14;16;17;19-21;52).”
BackgroundMeisinger, C., L�wel, H., Thorand, B., & D�ring, A. (2005) · Diabetologia · doi:10.1007/s00125-004-1604-3 · Cited by 209
Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma
Pomares, F. J., Canas, R., Rodriguez, J. M., Hernandez, A. M., Parrilla, P., & Tebar, F. J. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3751208.x · Cited by 124
A link between short sleep and obesity: building the evidence for causation
Cizza, G., Skarulis, M., & Mignot, E. (2005) · SLEEP · doi:10.1093/sleep/28.10.1217 · Cited by 111 · cited 1×
“Every 3 hours during wake periods, subjects completed a short test battery including the Karolinska Sleepiness Scale (34) and the Psychomotor Vigilance Task (PVT) (3,24).”
MethodSt. Hilaire, M. A., Klerman, E. B., Khalsa, S. B. S., Wright, K. P., Czeisler, C. A., & Kronauer, R. E. (2007) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2007.04.001 · Cited by 109
Buxton, O. M., Quintiliani, L. M., Yang, M. H., Ebbeling, C. B., Stoddard, A. M., Pereira, L. K., & Sorensen, G. (2009) · American Journal of Public Health · doi:10.2105/ajph.2008.158501 · Cited by 95 · cited 1×
“Thus, the current study did not allow behavioral changes in diet composition (43), caloric intake, or activity/exercise levels that may have contributed to the association of reduced habitual sleep duration and metabolic dysregulation in previous studies.”
BackgroundSelf-citation(2006) · CRC Press eBooks · doi:10.3109/9781420019254 · Cited by 95
Tripathy, D., Wessman, Y., Gullström, M., Tuomi, T., & Groop, L. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1395 · Cited by 74 · cited 1×
“Other authors, in validating different types of metabolic challenge tests, have demonstrated the reproducibility of the test results, especially for SI (50).”
BackgroundModafinil elicits sympathomedullary activation
Taneja, I., Diedrich, A., Black, B. K., Byrne, D. W., Paranjape, S. Y., & Robertson, D. (2005) · Hypertension · doi:10.1161/01.hyp.0000158267.66763.63 · Cited by 68
(1969) · PubMed · Cited by 58
Mitchell, H. A., Bogenpohl, J. W., Liles, L. C., Epstein, M. P., Bozyczko-Coyne, D., Williams, M., & Weinshenker, D. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.07.014 · Cited by 51 · cited 1×
“Modafanil activates central, wake-promoting dopaminergic and noradrenergic mechanisms (25;26) and ameliorates the adverse effects of sleep deprivation on alertness and performance (27-29), impairments in which have been attributed to reduced brain glucose utilization (30).”
Background(2004) · PubMed · Cited by 27
Sleep Disorders: Their Impact on Public Health
Malhotra, R. K. (2008) · JAMA · doi:10.1001/jama.299.13.1612 · Cited by 9
Modafinil: mechanisms of action
(2006) · Narcolepsy and Hypersomnia · doi:10.3109/9781420019254-54 · Cited by 1
Research works printed but not linked: 2
- Hale, 2007, Does the demography of sleep contribute to health disparities?, 1
- Caraway, 1987, Carbohydrates, 422
Cited by
Marino, M., Li, Y., Rueschman, M. N., Winkelman, J. W., Ellenbogen, J. M., Solet, J. M., Dulin, H., Berkman, L. F., & Buxton, O. M. (2013) · Sleep · doi:10.5665/sleep.3142 · Cited by 1,056
Self-citationSt-Onge, M.-P., Grandner, M. A., Brown, D., Conroy, M. B., Jean-Louis, G., Coons, M., & Bhatt, D. L. (2016) · Circulation · doi:10.1161/cir.0000000000000444 · Cited by 1,044
Buxton, O. M., Cain, S. W., O’Connor, S. P., Porter, J. H., Duffy, J. F., Wang, W., Czeisler, C. A., & Shea, S. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003200 · Cited by 932
“Although a decreased insulin response to a more metabolically challenging glucose tolerance test has been reported in one sleep restriction study (1), two more recent studies have not observed this change (3, 31).”
BackgroundInfluentialSelf-citationPanel, C. C., Watson, N. F., Badr, M. S., Belenky, G., Bliwise, D. L., Buxton, O. M., Buysse, D., Dinges, D. F., Gangwisch, J., Grandner, M. A., et al. (2015) · Sleep · doi:10.5665/sleep.4886 · Cited by 906
Self-citationSleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies
Shan, Z., Ma, H., Xie, M., Yan, P., Guo, Y., Bao, W., Rong, Y., Jackson, C. L., Hu, F. B., & Liu, L. (2015) · Diabetes Care · doi:10.2337/dc14-2073 · Cited by 902
Metadata
- Authors
- Buxton, O. M., Pavlova, M., Reid, E. W., Wang, W., Simonson, D. C., & Adler, G. K.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Buxton, Orfeu M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-06-28
- Volume
- 59
- Issue
- 9
- Pages
- 2126-2133
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2927933
- OpenAlex
- W2162026342
- Cited by
- 604
- References
- 62
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 36 · 2023: 34 · 2022: 46 · 2021: 46 · 2020: 41 · 2019: 37 · 2018: 44 · 2017: 33 · 2016: 49 · 2015: 44 · 2014: 35 · 2013: 44 · 2012: 31
- FWCI
- 44.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Brigham and Women's Hospital (M01 RR02635)
- National Institutes of Health (RR‐02635)
- National Institute on Aging (P01AG009975)
- National Center for Research Resources (M01RR002635)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Keywords
- sleep restriction, insulin sensitivity, modafinil, glucose tolerance, insulin resistance, insulin secretion, cortisol, catecholamines, slow-wave sleep, disposition index, short sleep duration, healthy men
- MeSH terms
- Modafinil, Adult, Central Nervous System Stimulants, Attention, Basal Metabolism, Benzhydryl Compounds, Blood Glucose, Calorimetry, Indirect, Double-Blind Method, Glucose Tolerance Test, Humans, Hyperinsulinism, Insulin, Male, Reference Values, Sleep Deprivation, Wakefulness, Glucose Clamp Technique, Patient Selection, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.